MI
CELZ icon

Motiv8 Investments’s Creative Medical Technology CELZ Stock Holding History

Motiv8 Investments’s Portfolio CELZ Stock Details CELZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$0 Buy
+1
New +$3 ﹤0.01% 918

Other funds holding CELZ

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Motiv8 Investments's CELZ Position: Q4 2025 in Review

Motiv8 Investments opened a new position in Creative Medical Technology (CELZ) in Q4 2025: 1 share worth $0. The stake represents ﹤0.01% of the portfolio and ranks #918 among its holdings.

14 funds tracked by Wall St. Rank hold CELZ as of Q4 2025.

  • Motiv8 Investments held 1 share of Creative Medical Technology worth $0 as of Q4 2025.
  • Creative Medical Technology was a new Motiv8 Investments position in Q4 2025.
  • Creative Medical Technology made up ﹤0.01% of Motiv8 Investments's portfolio in Q4 2025, its #918 holding.
  • 14 funds tracked by Wall St. Rank held Creative Medical Technology as of Q4 2025.

Based on Motiv8 Investments's 13F filing for Q4 2025, filed 13 Feb 2026.